LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)

HCV 和 HIV-1 双重感染受试者的长期抗病毒治疗 (SLAM-C)

• 批准号: 7716808
• 负责人: DAVID A WOHL
• 金额: $ 0.73万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716808
• 关键词: Antiviral Agents; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Hepatitis C; Hepatitis C virus; Institution; Liver; Purpose; Rate; Research; Research Personnel; Resources; Source; United States National Institutes of Health; peginterferon alfa-2a

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out if long-term treatment with pegylated-interferon alfa-2a (PEG-IFN) slow the rate of liver damage caused by hepatitis C in people who did not get rid of the hepatitis C virus with previous treatment.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是查明长期使用聚乙二醇化干扰素 α-2a (PEG-IFN) 治疗是否可以减缓既往未清除丙型肝炎病毒的人群中丙型肝炎引起的肝损伤速度。治疗。